a liquid preparation , in a dose of 60 ml qid ( 4.2 g/d ) , was 62 percent effective in preventing traveler 's diarrhea during a three-week period of risk and a tablet formulation ( bss 600 mg qid ) was 76 percent effective in preventing experimentally induced enterotoxigenic escherichia coli diarrhea in volunteers .
C0053792
bss
C0011991
diarrhea